Farmaceutica Remedia’s revenue in the first quarter grew by 6%, to RON54.8 million (EUR12.6 million), while expenses increased by 7%, to RON52 million (EUR11.9 million), according to information provided Wednesday to the Bucharest Stock Exchange.
This year, the company projects pre-tax profit of RON8.7 million, 61% higher on the year. Total revenue is seen up 27%, to RON260.8 million, while expenses are expected to increase by 16%, to RON252.4 million.
Farmaceutica Remedia has eight warehouses, a network of 53 pharmacies and seven directly-owned units.
According to the latest reports, Valentin Norbert Taru, chairman of the board, owns 66.05% of the company’s stock. The shareholders include businessman Lutz Stache, who owns 16.49% in his own name and through AHG Simcor Industry, the Romanian branch of German company AHG Industry, which he controls.
On Wednesday, Farmaceutica Remedia closed flat at RON0.251 per share. (EUR1=RON4.4168)